The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes
暂无分享,去创建一个
Francisco A. Chaves | Christopher A. Lazarski | K. Richards | A. Sant | J. M. Weaver | C. Lazarski | Scott A Jenks | S. Jenks | Jason M. Weaver | Andrea J. Sant | Francisco A. Chaves | Scott A. Jenks | Katherine A. Richards | Paula Menges | J. M. Weaver | Christopher A. Lazarski | P. Menges | Andrea J. Sant | Christopher A. Lazarski
[1] Francisco A. Chaves,et al. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. , 2005, Immunity.
[2] Francisco A. Chaves,et al. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. , 2005, Journal of immunological methods.
[3] Henry C. Chang,et al. Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.
[4] T. Tuschl,et al. Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy , 2005, Science.
[5] B. Kyewski,et al. Regulating self-tolerance by deregulating gene expression. , 2004, Current opinion in immunology.
[6] Michael D. Cahalan,et al. Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes , 2004, The Journal of experimental medicine.
[7] Philip J Norris,et al. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] B. Kyewski,et al. Self-representation in the thymus: an extended view , 2004, Nature Reviews Immunology.
[9] F. Koning,et al. Dissection of the HLA-DR4 Peptide Repertoire in Endocrine Epithelial Cells: Strong Influence of Invariant Chain and HLA-DM Expression on the Nature of Ligands1 , 2004, The Journal of Immunology.
[10] S. Sadegh-Nasseri,et al. The Magnitude of TCR Engagement Is a Critical Predictor of T Cell Anergy or Activation1 , 2004, The Journal of Immunology.
[11] C. Benoist,et al. Good riddance: Thymocyte clonal deletion prevents autoimmunity. , 2004, Current opinion in immunology.
[12] B. Evavold,et al. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes. , 2004, Molecular immunology.
[13] Mark J. Miller,et al. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Wiley,et al. Enhanced Catalytic Action of HLA-DM on the Exchange of Peptides Lacking Backbone Hydrogen Bonds between their N-Terminal Region and the MHC Class II α-Chain1 , 2004, The Journal of Immunology.
[15] S. Henrickson,et al. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.
[16] B. Evavold,et al. Modification of peptide interaction with MHC creates TCR partial agonists. , 2004, Cellular immunology.
[17] E. Unanue,et al. Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing 1 , 2003, The Journal of Immunology.
[18] Pamela S. Ohashi,et al. TCR Binding Kinetics Measured with MHC Class I Tetramers Reveal a Positive Selecting Peptide with Relatively High Affinity for TCR 1 , 2003, The Journal of Immunology.
[19] Antonio Lanzavecchia,et al. Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.
[20] A. Sette,et al. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.
[21] M. Jenkins,et al. Antigen presentation to naive CD4 T cells in the lymph node , 2003, Nature Immunology.
[22] J. Elliott,et al. Editing of an Immunodominant Epitope of Glutamate Decarboxylase by HLA-DM1 , 2003, The Journal of Immunology.
[23] Mark M Davis,et al. Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.
[24] A. Rudensky,et al. Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.
[25] H. Reijonen,et al. Low‐avidity recognition by CD4+ T cells directed to self‐antigens , 2003, European journal of immunology.
[26] Chad H. Koonce,et al. DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements 1 , 2003, The Journal of Immunology.
[27] Antonio Lanzavecchia,et al. T cell fitness determined by signal strength , 2003, Nature Immunology.
[28] H. Reijonen,et al. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. , 2003, Methods.
[29] Philippa Marrack,et al. Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.
[30] Ccggaattccatcacgtgttcgtggagact Tgtaaaacgacggccagtgc,et al. Second Class Minors : Molecular Identification of the Autosomal H 46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules , 2003 .
[31] F. Sallusto,et al. Opinion-decision making in the immune system: Progressive differentiation and selection of the fittest in the immune response , 2002, Nature Reviews Immunology.
[32] K. Wucherpfennig,et al. Structural Factors Contributing to DM Susceptibility of MHC Class II/Peptide Complexes1 , 2002, The Journal of Immunology.
[33] N. L. La Gruta,et al. The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues , 2002, The Journal of Immunology.
[34] Mark S. Anderson,et al. Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.
[35] L. Turka,et al. The Proliferative Capacity of Individual Naive CD4+T Cells Is Amplified by Prolonged T Cell Antigen Receptor Triggering , 2002, The Journal of experimental medicine.
[36] E. Ingulli,et al. In Situ Analysis Reveals Physical Interactions Between CD11b+ Dendritic Cells and Antigen-Specific CD4 T Cells After Subcutaneous Injection of Antigen1 , 2002, The Journal of Immunology.
[37] R. Locksley,et al. Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. , 2002, Immunity.
[38] David L. Woodland,et al. The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues1 , 2002, The Journal of Immunology.
[39] E. Unanue,et al. Cutting Edge: Chemical Dominance Does Not Relate to Immunodominance: Studies of the CD4+ T Cell Response to a Model Antigen , 2002, The Journal of Immunology.
[40] H. Ploegh,et al. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. , 2002, Current opinion in immunology.
[41] N. Viner,et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.
[42] N. K. Steede,et al. Structural Basis for Helper T-cell and Antibody Epitope Immunodominance in Bacteriophage T4 Hsp10 , 2002, Journal of Biological Chemistry.
[43] Laurence Zitvogel,et al. Antigen presentation and T cell stimulation by dendritic cells. , 2002, Annual review of immunology.
[44] L. Klein,et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self , 2001, Nature Immunology.
[45] L. Qi,et al. H2-O Inhibits Presentation of Bacterial Superantigens, but Not Endogenous Self Antigens1 , 2001, The Journal of Immunology.
[46] A. Sant,et al. Energetic asymmetry among hydrogen bonds in MHC class II⋅peptide complexes , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Blum,et al. Cutting Edge: Editing of Recycling Class II:Peptide Complexes by HLA-DM1 , 2001, The Journal of Immunology.
[48] Maria V. Tejada-Simon,et al. Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions1 , 2001, The Journal of Immunology.
[49] S. Jameson,et al. A Low Affinity TCR Ligand Restores Positive Selection of CD8+ T Cells In Vivo1 , 2001, The Journal of Immunology.
[50] F. Sallusto,et al. Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.
[51] Chad H. Koonce,et al. Relaxed DM Requirements During Class II Peptide Loading and CD4+ T Cell Maturation in BALB/c Mice1 , 2001, The Journal of Immunology.
[52] C. Watts,et al. Antigen processing in the endocytic compartment. , 2001, Current opinion in immunology.
[53] C. Nelson,et al. Structural and Functional Consequences of Altering a Peptide MHC Anchor Residue , 2001 .
[54] A. Khoruts,et al. In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.
[55] Scheherazade Sadegh-Nasseri,et al. Hla-Dm Recognizes the Flexible Conformation of Major Histocompatibility Complex Class II , 2000, The Journal of experimental medicine.
[56] J. Kappler,et al. T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4+ T Cell Response in Vivo , 2000, The Journal of experimental medicine.
[57] A. Smith,et al. Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. , 2000 .
[58] Philippa Marrack,et al. T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.
[59] A. Sant,et al. Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes , 2000, The Journal of experimental medicine.
[60] P. Cresswell,et al. Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. , 2000, The Journal of biological chemistry.
[61] E. Sercarz,et al. Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display1 , 2000, The Journal of Immunology.
[62] B. Chain,et al. Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation. , 2000, Seminars in Cell and Developmental Biology.
[63] B. Evavold,et al. DO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope1 , 2000, The Journal of Immunology.
[64] S. Landry. Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120. , 2000, Journal of theoretical biology.
[65] L. Karlsson,et al. Nonclassical MHC class II molecules. , 2000, Annual review of immunology.
[66] D. Zaller,et al. Role of APC in the selection of immunodominant T cell epitopes. , 1999, Journal of immunology.
[67] T. Lybrand,et al. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. , 1999, Biochemistry.
[68] G. Hämmerling,et al. The impact of the non‐classical MHC proteins HLA‐DM and HLA‐DO on loading of MHC class II molecules , 1999, Immunological reviews.
[69] G. Hämmerling,et al. Quality control of MHC class II associated peptides by HLA-DM/H2-M. , 1999, Seminars in immunology.
[70] S. Ceman,et al. Individual hydrogen bonds play a critical role in MHC class II:peptide interactions: implications for the dynamic aspects of class II trafficking and DM‐mediated peptide exchange , 1999, Immunological reviews.
[71] J. Borghans,et al. Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Tompkins,et al. Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice. , 1999, Journal of immunology.
[73] P. Marrack,et al. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[74] J. Panus,et al. Evolution of Antigen-specific T Cell Receptors In Vivo: Preimmune and Antigen-driven Selection of Preferred Complementarity-determining Region 3 (CDR3) Motifs , 1999, The Journal of experimental medicine.
[75] P. Allen,et al. A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.
[76] G. Hämmerling,et al. Identification of destabilizing residues in HLA class II‐selected bacteriophage display libraries edited by HLA‐DM , 1999, European journal of immunology.
[77] Jason G. Cyster,et al. Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.
[78] P. Fairchild,et al. Reversal of immunodominance among autoantigenic T-cell epitopes. , 1999, Autoimmunity.
[79] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[80] D. Weber,et al. HLA-DM and the MHC class II antigen presentation pathway , 1999, Immunologic research.
[81] M. Mcgrath. The lysosomal cysteine proteases. , 1999, Annual review of biophysics and biomolecular structure.
[82] E. Sercarz,et al. Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: implications for autoimmunity and infection. , 1998, Journal of immunology.
[83] D. Hanahan,et al. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. , 1998, Current opinion in immunology.
[84] C. Benoist,et al. The phenotype of H‐2M‐deficient mice is dependent on the MHC class II molecules expressed , 1998, European journal of immunology.
[85] E. Ingulli,et al. Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.
[86] Paul V. Lehmann,et al. Endogenous Myelin Basic Protein Inactivates the High Avidity T Cell Repertoire , 1998, The Journal of experimental medicine.
[87] E. Sercarz,et al. Modulation of the immunogenicity of antigenic determinants by their flanking residues. , 1998, Immunology today.
[88] T. Hunkapiller,et al. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. , 1998, Immunity.
[89] H. Grey,et al. The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[90] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[91] P. A. Peterson,et al. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.
[92] J. Cabaniols,et al. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. , 1998, Journal of immunology.
[93] M. Hofnung,et al. Immunodominance does not result from peptide competition for MHC class II presentation. , 1998, Journal of immunology.
[94] A. Rudensky,et al. Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo , 1998, The Journal of experimental medicine.
[95] A. Lanzavecchia,et al. The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.
[96] E. Sercarz,et al. Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. , 1997, Journal of immunology.
[97] D. Vignali,et al. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. , 1997, Immunity.
[98] J. McCluskey,et al. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. , 1997, International immunology.
[99] R. Lechler,et al. In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[100] G. Hämmerling,et al. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules. , 1997, Human immunology.
[101] J. Cabaniols,et al. Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity. , 1997, Cellular immunology.
[102] E. Unanue,et al. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. , 1997, Journal of immunology.
[103] J. Blum,et al. Antigen-presenting cells and the selection of immunodominant epitopes. , 1997, Critical reviews in immunology.
[104] A. Sant,et al. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. , 1996, Journal of immunology.
[105] P. Cresswell,et al. HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.
[106] G. Hämmerling,et al. Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.
[107] J. Trowsdale,et al. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs , 1996, The Journal of experimental medicine.
[108] A. Sant,et al. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.
[109] B. Evavold,et al. Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.
[110] T. Watts,et al. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells. , 1996, Journal of immunology.
[111] G. Hämmerling,et al. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[112] E. Unanue,et al. Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.
[113] E. Sercarz,et al. Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity. , 1996, Journal of autoimmunity.
[114] J. Altman,et al. Tracking antigen-specific helper T cell responses. , 1996, Current opinion in immunology.
[115] C. Benoist,et al. Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.
[116] H. Ruley,et al. H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.
[117] R. Busch,et al. Developing and shedding inhibitions: how MHC class II molecules reach maturity. , 1996, Current opinion in immunology.
[118] D. Wraith,et al. Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. , 1996, Immunology today.
[119] S. Tonegawa,et al. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system , 1995, European journal of immunology.
[120] P. Reay,et al. Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis. , 1995, Journal of immunology.
[121] D. Kioussis,et al. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. , 1995, Immunity.
[122] D. Weber,et al. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.
[123] P. Cresswell,et al. HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.
[124] D. Zaller,et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.
[125] R. Locksley,et al. Expression cloning of a protective Leishmania antigen. , 1995, Science.
[126] A. Chervonsky,et al. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent , 1995, The Journal of experimental medicine.
[127] P. Cresswell,et al. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. , 1995, Cell.
[128] P. L. Campbell,et al. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. , 1994, Journal of immunology.
[129] P. A. Peterson,et al. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. , 1994, Science.
[130] K. Wucherpfennig. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. , 1994, Clinical immunology and immunopathology.
[131] A. Finnegan,et al. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. , 1994, Journal of immunology.
[132] M. Hofnung,et al. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition. , 1994, Journal of immunology.
[133] Eric O Long,et al. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. , 1994, Journal of immunology.
[134] B. Arp,et al. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.
[135] Jeffrey A. Shaman,et al. An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.
[136] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[137] A. Sant. Endogenous antigen presentation by MHC class II molecules , 1994, Immunologic research.
[138] M. Hofnung,et al. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope , 1993, European journal of immunology.
[139] J. Smith,et al. Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants. , 1993, Journal of immunology.
[140] E. Sercarz,et al. The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[141] G. Loss,et al. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways , 1993, The Journal of experimental medicine.
[142] William Arbuthnot Sir Lane,et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.
[143] R. Locksley,et al. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.
[144] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[145] C. Rabourdin-Combe,et al. High efficiency of endogenous antigen presentation by MHC class II molecules. , 1992, International immunology.
[146] A Sette,et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.
[147] Eric O Long,et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells , 1992, Nature.
[148] M. Hofnung,et al. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.
[149] M. Hofnung,et al. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.
[150] J. Cabaniols,et al. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[151] L. Smith,et al. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex , 1991, The Journal of experimental medicine.
[152] K. Rock,et al. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. , 1991, Journal of immunology.
[153] M. Davis,et al. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH , 1991, The Journal of experimental medicine.
[154] J. McCluskey,et al. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[155] E. Sercarz,et al. T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes , 1991, The Journal of experimental medicine.
[156] A. Taylor,et al. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.
[157] M. Bekoff,et al. Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[158] F. Cardinaux,et al. In vivo competition between self peptides and foreign antigens in T-cell activation , 1988, Nature.
[159] K. Cease,et al. Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing , 1988, The Journal of experimental medicine.
[160] R. Titus,et al. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. , 1986, Journal of immunology.
[161] J. Berzofsky,et al. T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. , 1985, Journal of immunology.
[162] J. Berzofsky,et al. Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. , 1984, Journal of immunology.
[163] A Wlodawer,et al. The refined crystal structure of ribonuclease A at 2.0 A resolution. , 1982, The Journal of biological chemistry.